The official described our study as "fairly straightforward" and said that there is concern that drugs involved were "not meant to be inhaled."
Clearly, federal regulatory agencies must assess risk and set guidelines for these types of machines and establish procedures to monitor the health impact on pharmacy workers when they are used.
The previous press release, the executive summary and the full study
are available for review.
About AlburtyLab, Inc.
AlburtyLab is an independent laboratory located in Drexel, Missouri that serves the aerosol research, development, and instrumentation communities. AlburtyLab has conducted independent studies for a range of agencies and companies, including Boeing/US Navy, Boston Scientific, Northrop Grumman, US Postal Service, US Department of Homeland Security, and the US Army Research Laboratory.
Technical questions may be directed to Mr. Alburty at (816) 619-3374 or via email to firstname.lastname@example.org.
This study was funded by one of the technologies reviewed in the evaluation, ScriptPro LLC of Mission, Kansas.
The Executive Summary and the final report can be found at http://www.alburtylab.com
*1 NIOSH (National Institute of Occupational Safety and Health) that created testing specifications required by OSHA.
Contact: Josh Fenton, The Fenton Group
|SOURCE AlburtyLab, Inc.|
Copyright©2008 PR Newswire.
All rights reserved